share_log

The Recent Pullback Must Have Dismayed Contec Medical Systems Co.,Ltd (SZSE:300869) Insiders Who Own 61% of the Company

The Recent Pullback Must Have Dismayed Contec Medical Systems Co.,Ltd (SZSE:300869) Insiders Who Own 61% of the Company

最近的回調一定讓擁有61%股份的康泰醫學系統有限公司(深圳證券交易所代碼:300869)內部人士感到沮喪。
Simply Wall St ·  2024/12/20 06:10

Key Insights

關鍵洞察

  • Contec Medical SystemsLtd's significant insider ownership suggests inherent interests in company's expansion
  • The top 2 shareholders own 59% of the company
  • Past performance of a company along with ownership data serve to give a strong idea about prospects for a business
  • 康泰醫學系統有限公司的重大內部股權表明其對公司擴張的固有利益。
  • 前兩大股東持有公司59%的股份。
  • 公司的過往表現以及所有權數據有助於強烈判斷業務的前景

To get a sense of who is truly in control of Contec Medical Systems Co.,Ltd (SZSE:300869), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 61% to be precise, is individual insiders. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

要了解誰真正控制着康泰醫學系統有限公司(SZSE:300869),了解企業的股權結構是很重要的。 持有公司最多股份的集團,大約61%,實際上是個人內部人士。 換句話說,這個集團從對公司的投資中最有可能獲得最大收益(或承擔最大損失)。

As market cap fell to CN¥6.2b last week, insiders would have faced the highest losses than any other shareholder groups of the company.

上週市場市值降至62億人民幣,內部人士面臨的損失高於該公司的其他任何股東群體。

Let's take a closer look to see what the different types of shareholders can tell us about Contec Medical SystemsLtd.

讓我們更仔細地看看不同類型的股東能告訴我們關於康泰醫學有限公司的信息。

big
SZSE:300869 Ownership Breakdown December 19th 2024
SZSE:300869 股權結構 2024年12月19日

What Does The Institutional Ownership Tell Us About Contec Medical SystemsLtd?

機構持股情況能告訴我們關於康泰醫學有限公司什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。

Since institutions own only a small portion of Contec Medical SystemsLtd, many may not have spent much time considering the stock. But it's clear that some have; and they liked it enough to buy in. If the company is growing earnings, that may indicate that it is just beginning to catch the attention of these deep-pocketed investors. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too.

由於機構僅持有康泰醫學有限公司的一小部分股份,許多人可能沒有花太多時間考慮這隻股票。但顯然,有些人已經注意到了;而他們對購買此股票的興趣足夠大。如果公司在增加盈利,這可能表明它剛剛開始吸引這些財力雄厚的投資者的注意。當一些大型機構想同時購買某隻股票時,我們有時會看到股價上漲。下面你可以看到歷史的盈利和營業收入,這對考慮更多的機構投資者是否會想要這隻股票也可能有所幫助。當然,還有許多其他因素需要考慮。

big
SZSE:300869 Earnings and Revenue Growth December 19th 2024
SZSE:300869 2024年12月的盈利和營業收入增長

Hedge funds don't have many shares in Contec Medical SystemsLtd. Looking at our data, we can see that the largest shareholder is Kun Hu with 47% of shares outstanding. With 12% and 0.6% of the shares outstanding respectively, Guili Wang and Chunyuan Fu are the second and third largest shareholders. In addition, we found that Yang Zhishan, the CEO has 0.5% of the shares allocated to their name.

對沖基金在康泰醫學有限公司的股份不多。根據我們的數據,最大股東是Kun Hu,持有47%的流通股。Guili Wang和Chunyuan Fu分別是第二和第三大股東,持有12%和0.6%的流通股。此外,我們發現CEO楊志山名下有0.5%的股份。

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

經過進一步挖掘,我們發現前兩大股東共同控制了公司一半以上的股份,這意味着他們在影響公司決策方面有相當大的權力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.

雖然研究一個公司的機構所有權可以爲你的研究增加價值,但同時研究分析師的推薦也是一個很好的做法,以更深入了解股票的預期表現。我們提供的信息表明該股票沒有分析師的覆蓋,因而可能知名度不高。

Insider Ownership Of Contec Medical SystemsLtd

康泰醫學有限公司的內部持股情況

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

內部人的定義在不同國家之間可能略有不同,但董事會成員始終被算作內部人。管理層最終向董事會負責。然而,管理者成爲執行董事會成員並不罕見,特別是當他們是創始人或首席執行官時。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部持股是積極的,因爲這表明董事會與其他股東保持良好的一致性。然而,在某些情況下,權力在這個群體中過於集中。

Our information suggests that insiders own more than half of Contec Medical Systems Co.,Ltd. This gives them effective control of the company. So they have a CN¥3.8b stake in this CN¥6.2b business. Most would be pleased to see the board is investing alongside them. You may wish todiscover (for free) if they have been buying or selling.

我們的信息顯示,內部人士擁有康泰醫學系統有限公司超過一半的股份。這使他們對公司具有有效的控制權。因此,他們在這個62億人民幣的業務中擁有38億人民幣的股份。大多數人會很高興看到董事會與他們共同投資。您可能希望(免費)了解他們是否一直在買入或賣出。

General Public Ownership

公衆持股

The general public-- including retail investors -- own 37% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

公衆,包括散戶投資者,持有該公司37%的股份,因此不能輕易被忽視。這種股份規模雖然可觀,但如果決策與其他大型股東不同,可能不足以改變公司政策。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Contec Medical SystemsLtd has 2 warning signs we think you should be aware of.

雖然考慮擁有一家公司不同團體的情況非常重要,但還有其他更重要的因素。 例如,風險 - 康泰醫學系統有限公司有2個警告信號,我們認爲你應該注意。

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

當然,這可能不是買入的最佳股票。因此,您可能希望查看我們免費的有趣前景集合,擁有良好的財務狀況。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論